title: Proteomic analysis of Alzheimer's disease cerebrospinal fluid from neuropathologically diagnosed subjects.
abstract: A crucial need exists for reliable Alzheimer's disease (AD) diagnostic and prognostic tests. Given its intimate communication with the brain, the cerebrospinal fluid (CSF) has been surveyed intensively for reliable AD biomarkers. The heterogeneity of AD pathology and the unavoidable difficulties associated with the clinical diagnosis and differentiation of this dementia from other pathologies have confounded biomarker studies in antemortem CSF samples. Using postmortem ventricular CSF (V-CSF) pools, two-dimensional difference gel electrophoresis (2D DIGE) analyses revealed a set of proteins that showed significant differences between neuropathologically-diagnosed AD and elderly non-demented controls (NDC), as well as subjects with non-AD dementias. The 2D DIGE system identified a set of 21 different protein biomarkers. This panel of proteins probably reflects fundamental pathological changes that are divergent from both normal aging and non-AD dementias.
authors.affiliation: The Longtine Center for Molecular Biology and Genetics, Sun Health Research Institute, Sun City, Arizona 85351, USA.
authors.forename: Chera L
authors.initials: CL
authors.lastname: Maarouf
authors.forename: Tracy M
authors.initials: TM
authors.lastname: Andacht
authors.forename: Tyler A
authors.initials: TA
authors.lastname: Kokjohn
authors.forename: Eduardo M
authors.initials: EM
authors.lastname: Castaño
authors.forename: Lucia I
authors.initials: LI
authors.lastname: Sue
authors.forename: Thomas G
authors.initials: TG
authors.lastname: Beach
authors.forename: Alex E
authors.initials: AE
authors.lastname: Roher
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000134:cerebrospinal fluid* / Q000175:diagnosis; D000704:Analysis of Variance; D015415:Biomarkers / Q000134:cerebrospinal fluid*; D015180:Electrophoresis, Gel, Two-Dimensional; D005260:Female; D006801:Humans; D008297:Male; D013058:Mass Spectrometry; D020543:Proteome; D040901:Proteomics; D016875:tau Proteins / Q000134:cerebrospinal fluid
chemical_list: D015415:Biomarkers; D020543:Proteome; D016875:tau Proteins
references.citation: Alzheimers Dement. 2008 Mar;4(2):110-33
references.pmid: 18631956
references.citation: Exp Gerontol. 2000 Jul;35(4):473-9
references.pmid: 10959035
references.citation: Arch Neurol. 2001 Nov;58(11):1790-2
references.pmid: 11708985
references.citation: Neurobiol Aging. 2007 May;28(5):713-8
references.pmid: 16698124
references.citation: Neurobiol Aging. 1998 Nov-Dec;19(6):535-43
references.pmid: 10192212
references.citation: Proteomics. 2008 Mar;8(6):1292-301
references.pmid: 18271068
references.citation: Acta Neuropathol. 2007 May;113(5):501-11
references.pmid: 17372746
references.citation: Clin Chim Acta. 2001 Aug 20;310(2):173-86
references.pmid: 11498083
references.citation: J Alzheimers Dis. 2002 Apr;4(2):115-22
references.pmid: 12214135
references.citation: Hum Mutat. 2006 Jun;27(6):532-7
references.pmid: 16652347
references.citation: J Lipid Res. 1990 Mar;31(3):545-8
references.pmid: 2341813
references.citation: Neurology. 2007 Oct 16;69(16):1569-79
references.pmid: 17761554
references.citation: Alzheimers Dement. 2008 Jan;4(1):38-48
references.pmid: 18631949
references.citation: Lancet Neurol. 2006 Mar;5(3):228-34
references.pmid: 16488378
references.citation: J Neuropathol Exp Neurol. 1997 Oct;56(10):1095-7
references.pmid: 9329452
references.citation: N Engl J Med. 1998 Feb 19;338(8):506-11
references.pmid: 9468467
references.citation: Neurology. 1991 Apr;41(4):479-86
references.pmid: 2011243
references.citation: Nature. 2008 Aug 28;454(7208):1065-71
references.pmid: 18756247
references.citation: Funct Neurol. 2008 Apr-Jun;23(2):93-6
references.pmid: 18671910
references.citation: J Neurochem. 1995 Jan;64(1):443-6
references.pmid: 7798944
references.citation: Lancet Neurol. 2007 Aug;6(8):734-46
references.pmid: 17616482
references.citation: Neurosci Lett. 1995 Jan 2;183(1-2):43-5
references.pmid: 7746484
references.citation: J Alzheimers Dis. 2008 May;14(1):17-25
references.pmid: 18525124
references.citation: Neurol Res. 2006 Mar;28(2):155-63
references.pmid: 16551433
references.citation: Neurology. 2007 Feb 27;68(9):666-9
references.pmid: 17325273
references.citation: J Neurochem. 2001 Mar;76(5):1411-20
references.pmid: 11238726
references.citation: Neuroreport. 2002 Jul 19;13(10):1291-4
references.pmid: 12151789
references.citation: J Neural Transm Suppl. 1998;53:169-80
references.pmid: 9700655
references.citation: Nat Struct Biol. 1996 Aug;3(8):676-81
references.pmid: 8756325
references.citation: Brain Res. 2000 Jan 24;853(2):344-51
references.pmid: 10640633
references.citation: Med Hypotheses. 2004;63(1):115-7
references.pmid: 15193361
references.citation: J Biol Chem. 1999 Jun 4;274(23):15990-5
references.pmid: 10347147
references.citation: Int J Hyperthermia. 2005 Aug;21(5):421-31
references.pmid: 16048839
references.citation: Mol Cell Neurosci. 2006 Feb;31(2):263-72
references.pmid: 16260146
references.citation: Drugs Today (Barc). 2007 Jun;43(6):423-31
references.pmid: 17612711
references.citation: Curr Clin Pharmacol. 2008 May;3(2):123-31
references.pmid: 18700307
references.citation: Clin Chem. 2006 Oct;52(10):1906-13
references.pmid: 16887899
references.citation: Hippocampus. 1994 Apr;4(2):210-25
references.pmid: 7951696
references.citation: J Neural Transm Park Dis Dement Sect. 1994;8(3):183-91
references.pmid: 7748462
references.citation: J Int Neuropsychol Soc. 2008 Jul;14(4):582-90
references.pmid: 18577287
references.citation: Mol Immunol. 2007 Feb;44(5):999-1010
references.pmid: 16698083
references.citation: Brain Res Mol Brain Res. 2003 Oct 21;118(1-2):140-6
references.pmid: 14559363
references.citation: Biochem Biophys Res Commun. 1999 May 10;258(2):241-6
references.pmid: 10329371
references.citation: Intern Med. 1995 Jun;34(6):481-4
references.pmid: 7549128